All Jay Patel articles
-
News
Pfizer and Novo Nordisk battle for obesity market dominance
Novo Nordisk’s “bold” $6.5 billion bid subject to a final verdict by Metsera’s board of directors.
Novo Nordisk’s “bold” $6.5 billion bid subject to a final verdict by Metsera’s board of directors.